How to Demonstrate the Clinical Impact of Off-Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation

被引：0
|
作者：
Kataoka, Naoya [1 ]
Imamura, Teruhiko [1 ]
机构：
[1] Univ Toyama, Dept Internal Med 2, Toyama, Japan
来源：
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY | 2025年
关键词：
D O I：
10.1111/jce.16591
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Effectiveness and Safety of Off-Label Dose-Reduced Direct Oral Anticoagulants in Atrial Fibrillation
    Arbel, Ronen
    Sergienko, Ruslan
    Hammerman, Ariel
    Greenberg-Dotan, Sari
    Batat, Erez
    Avnery, Orly
    Ellis, Martin H.
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (07): : 847 - +
  • [12] Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis
    Zhang, Xin-Lin
    Zhang, Xiao-Wen
    Wang, Ting-Yu
    Wang, Hong-Wei
    Chen, Zheng
    Xu, Biao
    Xu, Wei
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (12): : 1224 - 1237
  • [13] REPLY: Off-Label Use of Direct Oral Anticoagulants in Patients With Mitral Stenosis
    Kim, Ju Youn
    Kim, Sung-Hwan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (25) : 3362 - 3363
  • [14] Off-label direct oral anticoagulants dosing in atrial fibrillation and venous thromboembolism is associated with higher mortality
    Aguilar, Francisco
    Lo, Kevin B.
    Quintero, Eduardo E.
    Torres, Ricardo J.
    Hung, Wikien A.
    Albano, Jeri C.
    Alviz, Isabella
    Rodriguez, Carlos
    Garcia, Mario J.
    Romero, Jorge
    Slipczuk, Leandro
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2021, 19 (12) : 1119 - 1126
  • [15] An Updated Pooled Analysis of Off-Label Under and Over-Dosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation
    Shen, Nan-Nan
    Ferroni, Eliana
    Amidei, Claudio Barbiellini
    Canova, Cristina
    Peron, Viviana
    Wang, Jia-Liang
    Lin, Hou-Wen
    Gu, Zhi-Chun
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [16] Characteristics and Outcomes in Patients With Atrial Fibrillation (af) Receiving Direct Oral Anticoagulants (doacs) in off-Label Dose.
    Sarrazin, Vaughan Mary S.
    Briasoulis, Alexandros
    Leira, Enrique C.
    STROKE, 2019, 50
  • [17] Off-Label Use of Direct Oral Anticoagulants in Intracerebral Hemorrhage Patients With Prosthetic Valves
    Chaturvedi, Seemant
    Molina, Carlos A.
    Selim, Magdy H.
    Diener, Hans-Christoph
    Hohnloser, Stefan H.
    STROKE, 2017, 48 (11) : 3183 - 3186
  • [18] Direct oral anticoagulants (DOACs) use in patients with cardiac implantable devices and non-valvular atrial fibrillation: impact of off-label dose use in safety and efficacy outcomes
    Santos, Joana
    Antonio, Natalia
    Goncalves, Lino
    Rocha, Marilia J.
    Fortuna, Ana
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (06) : 1773 - 1773
  • [19] WIDESPREAD OFF-LABEL USE OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH LEFT VENTRICULAR THROMBUS
    Shi, Boqun
    Wang, Haoyu
    Song, Chenxi
    Yin, Dong
    Wang, Hongjian
    Dou, Ke Fei
    Song, Weihua
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1028 - 1028
  • [20] Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation
    Yu, Hee Tae
    Yang, Pil-Sung
    Jang, Eunsun
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Kim, Jong-Youn
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Lip, Gregory Y. H.
    Joung, Boyoung
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (12):
12345